Determination of elemental impurities in leachate solutions from syringes using sector field ICP-mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 77, Issue , 2013, Pages 139-144

  Van Hoecke, K ^a   Catry, C ^b   Vanhaecke, F ^a  

^a GHENT UNIVERSITY   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Elemental impurities; Guideline; ICP MS; Leachables; Prefilled syringes

Indexed keywords

ALUMINUM; SILICON; SODIUM; TUNGSTEN;

ARTICLE; CATALYST; CONCENTRATION (PARAMETERS); LEACHING; MASS SPECTROMETRY; PRIORITY JOURNAL; SYRINGE;

DRUG CONTAMINATION; MASS SPECTROMETRY; SOLUTIONS; SPECTROPHOTOMETRY, ATOMIC; SYRINGES;

EID: 84873673067     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.01.021     Document Type: Article

References (30)

1. DeStefano A.J., Zaidi K., Cecil T.L., Giancaspro G.I., U.S.P.Elemental Impurities Advisory Panel Elemental impurities - information. Pharmacopeial Forum 2010, 36:298-305.
2. Blake K. Stimuli to the revision process. Pharmacopeial Forum 1995, 21:1632-1637.
3. Wang T., Wu J., Hartman R., Jia X., Egan R.S. A multi-element ICP-MS survey method as an alternative to the heavy metals limit test for pharmaceutical materials. J. Pharm. Biomed. Anal. 2000, 23:867-890.
4. Lewen N., Mathew S., Schenkenberger M., Raglione T. A rapid ICP-MS screen for heavy metals in pharmaceutical compounds. J. Pharm. Biomed. Anal. 2004, 35:739-752.
5. Pharmacopoeia of the United States of America Procedure 121, Time-Limit Test for Heavy Elements, 8th revision 1905, Lippincott, Philadelphia, PA.
6. The United States Pharmacopeia Elemental impurities - limits 232. Pharmacopeial Forum 2010, 36:197-200.
7. The United States Pharmacopeia Elemental impurities - procedures 233. Pharmacopeial Forum 2010, 36:201-207.
8. The United States Pharmacopeia Elemental impurities - limits 232. Pharmacopeial Forum 2011, 37:1-6.
9. The United States Pharmacopeia Elemental impurities - procedures 233. Pharmacopeial Forum 2011, 37:1-16.
10. The United States Pharmacopeia, Elemental impurities - limits 232, Second supplement to USP 35-NF 30 (2012) 5633-5634.
11. The United States Pharmacopeia, Elemental impurities - procedures 233, Second supplement to USP 35-NF 30 (2012) 5635-5637.
12. The United States Pharmacopeia, <232> Elemental impurities - limits and <233> Elemental impurities - Procedures, revision bulletin, notice of postponement, 2012, to be consulted online at: http://www.usp.org/usp-nf/official-text/revision-bulletins/elemental-impurities-limits-and-elemental-impurities-procedures.
13. The United States Pharmacopeia, New quality standards limiting elemental impurities in medicines announced, Press release 23 May, Rockville, MD, 2012.
14. R. Soikes, Moving from vial to prefilled syringe, Pharmaceutical Technology, September 2009. To be consulted online at: http://www.pharmtech.com/pharmtech/article/articleDetail.jsp%3Fid=623096.
15. Kiang P. Future materials for prefilled syringe components. Am. Pharm. Rev. 2011, 14. To be consulted online at: http://www.americanpharmaceuticalreview.com/Featured-Articles/37276-Future-Materials-for-Prefilled-Syringe-Components/.
16. Sacha G.A., Saffell-Clemmer W., Abram K., Akers M.J. Practical fundamentals of glass, rubber, and plastic sterile packaging systems. Pharm. Dev. Technol. 2010, 15:6-34.
17. D. Jenke, Suitability-for-use considerations for prefilled syringes. Pharmaceutical Technology, April 2008. To be consulted online at: http://www.pharmtech.com/pharmtech/article/articleDetail.jsp%3Fid=505381.
18. Adler M. Challenges in the development of pre-filled syringes for biologics from a formulation scientists point of view. Am. Pharm. Rev. 2012, 15. To be consulted online at: http://www.americanpharmaceuticalreview.com/Featured-Articles/38372-Challenges-in-the-Development-of-Pre-filled-Syringes-for-Biologics-from-a-Formulation-Scientist-s-Point-of-View/.
19. Bee J.S., Nelson S.A., Freund E., Carpenter J.F., Randolph T.W. Precipitation of a monoclonal antibody by soluble tungsten. J. Pharm. Sci. 2009, 98:3290-3301.
20. Jiang Y., Nashed-Samuel Y., Li C., Liu W., Pollastrini J., Mallard D., Wen Z.-Q., Fujimori K., Pallitto M., Donahue L., Chu G., Torraca G., Vance A., Mire-Sluis A., Freund E., Davis J., Narhi L. Tungsten-induced protein aggregation: solution behavior. J. Pharm. Sci. 2009, 98:4695-4710.
21. Osterberg R.E. Potential toxicity of extractables and leachables in drug products. Am. Pharm. Rev. 2005, 8:64-67.
22. Van Hoecke K., Catry C., Vanhaecke F. Optimization of sample preparation and a quadrupole ICP-MS measurement protocol for the determination of elemental impurities in pharmaceutical substances in compliance with USP guidelines. J. Anal. At. Spectrom. 2012, 27:1909-1919.
23. Vanhaecke F., Vanhoe H., Dams R., Vandecasteele C. The use of internal standards in ICP-MS. Talanta 1992, 39:737-742.
24. Kettelhoit S. Industrial production of glass syringes. Pharm. Ind. 2008, 70:1261.
25. Nashed Samuel Y., Liu D., Fujimori K., Perez L., Lee H. Extractable and leachable implications on biological products in prefilled syringes. Am. Pharm. Rev. 2011, 14. To be consulted online at: http://www.americanpharmaceuticalreview.com/Featured-Articles/37011-Extractable-and-Leachable-Implications-on-Biological-Products-in-Prefilled-Syringes/.
26. The United States Pharmacopeia Evaluation of the inner surface durability of glass containers - briefing 1660. Pharmacopeial Forum 2012, 38:1-9.
27. Markovic I. Challenges associated with extractable and/or leachable substances in therapeutic biologic protein products. Am. Pharm. Rev. 2006, 9:20-27.
28. Yu X., Wood D., Ding X. Extractables and leachables study approach for disposable materials used in bioprocessing. Biopharm. Int. 2008, 21. To be consulted online at: http://www.biopharminternational.com/biopharm/Disposables/Extractables-and-Leachables-Study-Approach-for-Dis/ArticleStandard/Article/detail/490803?contextCategoryId=35801&ref=25.
29. Eakins M.N. Parenteral products: pharmacopeial control of containers, storage and distribution. Am. Pharm. Rev. 2011, 14. To be consulted online at: http://www.americanpharmaceuticalreview.com/Featured-Articles/37187-Parenteral-Products-Pharmacopeial-Control-of-Containers-Storage-and-Distribution/.
30. The United States Pharmacopeia In-process revision briefing USP 660 - containers - glass. Pharmacopeial Forum 2011, 37:1-19.